STADMIN

STADMIN

CDE Approves Stone’s Major Change

Major changes to Stone have been approved by the CDE. In June 2022, the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) reviewed and approved changes regarding the company name and manufacturing address for four product…